ShrimptonNPatukaleARaneM, et al. Cardiopulmonary bypass in a child with severe factor XII deficiency. Perfusion2021; 2021: 267659121999305.
2.
LaRuschGAMahdiFShariat-MadarZ, et al. Factor XII stimulates ERK1/2 and akt through uPAR, integrins, and the EGFR to initiate angiogenesis. Blood2010; 115: 5111–5120.
3.
YoshidaKTanakaSSatoY, et al. Global cerebral infarction after aortic arch replacement surgery in a patient with postoperatively revealed factor XII deficiency: a case report. J Med Case Rep2020; 14: 150.
4.
van VeenJJLaidlawSSwanevelderJ, et al. Contact factor deficiencies and cardiopulmonary bypass surgery: detection of the defect and monitoring of heparin. Eur J Haematol2009; 82: 208–212.
5.
FalterFMacDonaldSMatthewsC, et al. Evaluation of point-of-care ACT coagulometers and anti-Xa activity during cardiopulmonary bypass. J Cardiothorac Vasc Anesth2020; 34: 2921–2927.
6.
LehmanCMFrankEL.Laboratory monitoring of heparin therapy: partial thromboplastin time or Anti-Xa assay?Lab Med2009; 40: 47–51.
7.
De VriesAJLansink-HartgringAOFernhoutFJ, et al. The activated clotting time in cardiac surgery: should celite or kaolin be used?Interact Cardiovasc Thorac Surg2017; 24: 549–554.
8.
WoodMK.Congenital factor XII deficiency and cardiopulmonary bypass. Ann Thorac Surg1994;58: 1565.
9.
WallockMArentzenCPerkinsJ.Factor XII deficiency and cardiopulmonary bypass. Perfusion1995; 10: 13–16.
10.
PandeySVyasGN.Adverse effects of plasma transfusion. Transfusion2012; 52: 65S–79S.
